Nivolumab (Opdivo) Concentrate for Infusion from Germany
Nivolumab is a human monoclonal antibody PD-1 inhibitor for melanoma and lung cancer immunotherapy. Classified in HTS 3002.15.00.11 as it directly regulates immunological processes via checkpoint inhibition, in measured retail vials.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Provide PD-1 binding assay data; ensure oncology-specific FDA pathways
• Use validated cold chain with data loggers for immunotherapy stability